Let's look at real numbers.
Moving advances in research from the lab to the real world is frustratingly slow.
With "friends" like these, who needs enemies?
Arne Duncan's response to congressional legislation leads one to wonder.
Where do court decisions like Ariosa v. Sequenom leave the biotech industry?
The trouble with candidates who "tell it like it is" is that they're polarizing.
Obama has exercised a "light footprint" far beyond the range of the initial war on terror.
The case casts a shadow over the scope of agency deference.
Children are caught in the cross hairs of an antiquated immigration law.
Politicians and clever spin-masters cannot hold a candle to real transformative technology.